Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CB-01-11 in Infectious Diarrhoea
NCT03447821Phase 2Completed
- Sponsor
- Cosmo Pharmaceuticals
- Start
- Feb 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of rifamycin SV-MMX in gastroenteritis (3 arms), sponsored by Cosmo Pharmaceuticals. Primary endpoint: Time to Last Unformed Stool up to 7 days. Started Feb 2008; status: completed.
02
Drugs
rifamycin SV-MMX
03
Conditions
gastroenteritis
Beyond the preview
Go deeper on NCT03447821.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03447821.